Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2024 Recipient of RPB David F. Weeks Award for Outstanding Vision Research

Patricia Ann D’Amore, PhD, MBA, has been selected as the 2024 RPB David F. Weeks Award for Outstanding Vision Research (Weeks Award). Dr. D’Amore will receive her award and deliver a presentation during the AUPO 2024 Annual Meeting in Austin, Texas in February.

Mount Sinai Launches Center for Ophthalmic Artificial Intelligence and Human Health

The Icahn School of Medicine at Mount Sinai has launched the Center for Ophthalmic Artificial Intelligence and Human Health, the first of its kind in New York and one of the first in the United States.

Research to Prevent Blindness Announces New Sight-Saving Vision Research Grants

Research to Prevent Blindness (RPB) announces two new grants to support high-impact vision research. The new grants are the: RPB / Tom Wertheimer Career Development Award in Data Science and RPB / Mary Tyler Moore Vision Initiative Physician-Scientist Award.

ARVO Foundation Announces 2023 Recipient of Genentech Career Development Award for Underrepresented Minority Emerging Vision Scientists

The Association for Research in Vision and Ophthalmology (ARVO) Foundation congratulates Edmund Arthur, OD, PhD, the 2023 recipient of the Genentech Career Development Award for Underrepresented Minority (URM) Emerging Vision Scientists. Arthur will receive a two-year grant totaling $100,000 to support research and personnel costs for establishing an independent vision research program.

What Retina Specialists Want You to Know About Diabetes and Vision

If you’re living with Type 1 or Type 2 diabetes, you likely know how the condition can impact your overall health. But, focusing on how diabetes can affect your vision can go a long way toward maintaining your clear view of the world, according to the American Society of Retina Specialists (ASRS).

Diabetic Eye Disease: Awareness of Risks, Symptoms Can Save Your Sight

Diabetic retinopathy affects nearly 8 million Americans, and that number is expected to double by 2050, but knowing the risks and symptoms and seeking an early diagnosis and treatment from a retina specialist can preserve sight and virtually eliminate vision loss from the condition, according to the American Society of Retina Specialists (ASRS).

American Society of Retina Specialists (ASRS) Launches See for a Lifetime See a Retina Specialist Education Initiative to Drive Awareness and Action Around Retinal Diseases that Put Millions at Risk for Blindness

America’s retina specialists are warning the public that millions in the US who don’t know the facts about common retinal conditions such as age-related macular degeneration (AMD) and diabetic retinopathy are at risk for preventable blindness or vision loss from these sight stealing conditions.

Research News Tip Sheet: Story Ideas from Johns Hopkins Medicine

During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every other Wednesday.

Research News Tip Sheet: Story Ideas from Johns Hopkins Medicine

During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every other Tuesday.

AI algorithms detect diabetic eye disease inconsistently

Diabetes continues to be the leading cause of new cases of blindness among adults in the United States. But the current shortage of eye-care providers would make it impossible to keep up with demand to provide the requisite annual screenings for this population. A new study looks at the effectiveness of seven artificial intelligence-based screening algorithms to diagnose diabetic retinopathy, the most common diabetic eye disease leading to vision loss.

Un estudio descubre que los estadounidenses no conocen los síntomas y los riesgos de la retinopatía diabética

La retinopatía diabética es la causa más común de ceguera en los adultos de edad laboral; sin embargo, la mayoría de los estadounidenses de más de 40 años no conocen sus síntomas ni los factores de riesgo para esta afección común que amenaza la vista, según una encuesta encomendada por la Sociedad Estadounidense de Especialistas en Retina (American Society of Retina Specialists, ASRS).

American Society of Retina Specialists Launches Retina Health for Life Podcast

The American Society of Retina Specialists (ASRS) today announced the launch of a new audio and video podcast series providing consumers with critical information about the signs, symptoms and risk factors of retina disease and the importance of seeing a retina specialist for specialized care.

Exercise can slow or prevent vision loss, study finds

Exercise can slow or prevent the development of macular degeneration and may benefit other common causes of vision loss, such as glaucoma and diabetic retinopathy, new research suggests.

‘Primitive’ Stem Cells Shown to Regenerate Blood Vessels in The Eye

Johns Hopkins Medicine scientists say they have successfully turned back the biological hands of time, coaxing adult human cells in the laboratory to revert to a primitive state, and unlocking their potential to replace and repair damage to blood vessels in the retina caused by diabetes. The findings from this experimental study, they say, advance regenerative medicine techniques aimed at reversing the course of diabetic retinopathy and other blinding eye diseases.

For the evaluation and treatment of diabetic eye disease, ultra-wide field imaging techniques cannot be used interchangeably

Diabetic retinopathy can be diagnosed and graded with the use of a newer scanning technology called ultra-wide field (UWF) imaging, a system that generates high-quality pictures showing most of the retina. Research from the Joslin Diabetes Center’s Beetham Eye Institute has now shown that one technique, UFW fluorescein angiography, detects over three times more microaneurysms than UWF color imaging